{"id":766721,"date":"2026-07-16T17:58:09","date_gmt":"2026-07-16T17:58:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/766721\/"},"modified":"2026-07-16T17:58:09","modified_gmt":"2026-07-16T17:58:09","slug":"fda-approves-lipfendra-a-powerful-cholesterol-lowering-pill-from-merck","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/766721\/","title":{"rendered":"FDA approves Lipfendra, a powerful cholesterol-lowering pill from Merck"},"content":{"rendered":"<p id=\"anchor-94fa01\" class=\"body-graf\">The <a href=\"https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-first-oral-therapy-inhibits-proprotein-convertase-subtilisinkexin-type-9-pcsk9-lower\" target=\"_blank\" rel=\"nofollow noopener\">Food and Drug Administration<\/a> on Thursday approved a new cholesterol pill from Merck that works in a different way from statins.<\/p>\n<p><img decoding=\"async\" src=\"data:image\/svg+xml;base64,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\" alt=\"NBC News Icon\" class=\"styles_icon__wRwWv\" aria-hidden=\"true\"\/><\/p>\n<p class=\"styles_text__daaVB styles_textLarge__qlzwu\">Subscribe to read this story ad-free<\/p>\n<p class=\"styles_text__daaVB\">Get unlimited access to ad-free articles and exclusive content.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/media-cldnry.s-nbcnews.com\/image\/upload\/rockcms\/2026-01\/arrow-f55fa5.svg\" alt=\"arrow\" class=\"styles_arrow__tnruW\" aria-hidden=\"true\"\/><\/p>\n<p id=\"anchor-641b8f\" class=\"body-graf\">The daily pill, called Lipfendra, is known as a PCSK9 inhibitor \u2014 a class of powerful cholesterol-lowering medication that had previously only been available as injections. <\/p>\n<p id=\"anchor-832ccc\" class=\"body-graf\">The drug was approved for people with hypercholesterolemia, or high levels of LDL cholesterol, the so-called bad cholesterol. <\/p>\n<p id=\"anchor-9ac153\" class=\"body-graf\">About 1 in 4 adults in the U.S. have high LDL cholesterol, according to the <a href=\"https:\/\/www.heart.org\/en\/-\/media\/PHD-Files-2\/Science-News\/2\/2025-Heart-and-Stroke-Stat-Update\/2025-Statistics-At-A-Glance.pdf\" target=\"_blank\" rel=\"nofollow noopener\">American Heart Association<\/a>. Too much LDL cholesterol can lead to plaque buildup in the arteries, increasing the risk of heart disease and stroke.<\/p>\n<p id=\"anchor-0e0de6\" class=\"body-graf\">In one <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2511002\" target=\"_blank\" rel=\"nofollow noopener\">late-stage clinical trial<\/a>, Merck found that Lipfendra lowered LDL cholesterol levels by up to 60% after 24 weeks. In a <a href=\"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2841258\" target=\"_blank\" rel=\"nofollow noopener\">second trial<\/a>, people with a genetic condition called heterozygous familial hypercholesterolemia \u2014 which causes sky-high cholesterol from birth \u2014 saw similar reductions. Nearly all of the people in the trials were already taking a statin, and many were also taking a different cholesterol-lowering drug, ezetimibe.<\/p>\n<p id=\"anchor-745ec2\" class=\"body-graf\">In March, a group of major medical organizations, including the AHA and the American College of Cardiology, released <a href=\"https:\/\/www.nbcnews.com\/health\/heart-health\/cholesterol-lipids-guidelines-screenings-american-heart-association-rcna263017\" target=\"_blank\" rel=\"nofollow noopener\">new guidelines urging more aggressive treatment of cholesterol<\/a>. People without heart disease risk factors should aim to get their LDL cholesterol below 100 mg\/dL, people at high risk should aim for under 70 mg\/dL and for people with heart disease, under 55 mg\/dL. <\/p>\n<p id=\"anchor-9f92c0\" class=\"body-graf\">The drug works by blocking the PCSK9 protein, which is instrumental in the production of LDL cholesterol. Statins have a different target: an enzyme that the liver uses to make cholesterol.<\/p>\n<p id=\"anchor-679913\" class=\"body-graf\">The first PCSK9 inhibitor was approved in 2015. The drug, Repatha from Amgen, is an injectable. Regeneron and Sanofi also make an injection PCSK9 inhibitor called Praulent.  <\/p>\n<p id=\"anchor-c64045\" class=\"endmark body-graf\">Lipfendra will cost $10.50 a day, or $315 for a 30-day supply, according to Merck. The drugmaker expects the out-of-pocket cost will be lower. <\/p>\n","protected":false},"excerpt":{"rendered":"The Food and Drug Administration on Thursday approved a new cholesterol pill from Merck that works in a&hellip;\n","protected":false},"author":2,"featured_media":766722,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58],"tags":[97,243],"class_list":["post-766721","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-health","tag-medication"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/766721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=766721"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/766721\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/766722"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=766721"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=766721"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=766721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}